{
    "clinical_study": {
        "@rank": "67407", 
        "brief_summary": {
            "textblock": "The primary objectives are to demonstrate that MICARDIS\u00ae (telmisartan) is statistically\n      superior to Diovan\u00ae (valsartan) in reducing diastolic blood pressure (DBP) following a\n      missed dose at the end of a 6 to 8-week treatment period as measured by the 24-hour ABPM\n      mean and to demonstrate that MICARDIS\u00ae is statistically superior to Diovan\u00ae in reducing DBP\n      during the last 6-hours of the 24-hour dosing interval as measured by ABPM following a dose\n      of active study medication at the end of a 6 to 8-week treatment period."
        }, 
        "brief_title": "Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose", 
        "completion_date": "August 2002", 
        "condition": "Hypertension", 
        "condition_browse": {
            "mesh_term": "Hypertension"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        1.  Mild-to-moderate hypertension defined as a baseline mean seated DBP of greater than or\n        equal to 95 mm Hg and less than or equal to 109 mm Hg and a baseline 24-hour ABPM mean DBP\n        of greater than or equal to 85 mm Hg.\n\n        Exclusion Criteria:\n\n          1. Pre-menopausal women (last menstruation = 1 year prior to signing informed consent)\n             who:\n\n               -  Are not surgically sterile.\n\n               -  Are nursing.\n\n               -  Are of child-bearing potential and are NOT practicing acceptable methods of\n                  birth control, or do NOT plan to continue practicing an acceptable method\n                  throughout the study. Acceptable methods of birth control include IUD, oral,\n                  implantable or injectable contraceptives. No exceptions will be made.\n\n          2. Night shift workers who routinely sleep during the daytime and whose work hours\n             include midnight to 4:00 A.M.\n\n          3. Mean sitting SBP =180 mm Hg or mean sitting DBP =110 mm Hg during any visit of the\n             placebo run-in period.\n\n          4. Known or suspected secondary hypertension (i.e., pheochromocytoma).\n\n          5. Hepatic and/or renal dysfunction as defined by the following laboratory parameters:\n\n               -  SGPT (ALT) or SGOT (AST) > 2 times the upper limit of normal range.\n\n               -  Serum creatinine > 2.3 mg/dL (or > 203 \u00b5mol/l).\n\n          6. Bilateral renal artery stenosis, renal artery stenosis in a solitary kidney,\n             post-renal transplant patients or patients with only one kidney.\n\n          7. Clinically relevant sodium depletion, hypokalaemia or hyperkalaemia.\n\n          8. Uncorrected volume depletion.\n\n          9. Primary aldosteronism.\n\n         10. Hereditary fructose intolerance.\n\n         11. Biliary obstructive disorders.\n\n         12. Congestive heart failure (NYHA functional class CHF III-IV).\n\n         13. Unstable angina within the past three months prior to signing the informed consent\n             form.\n\n         14. Stroke within the past six months prior to signing the informed consent form.\n\n         15. Myocardial infarction or cardiac surgery within the past three months prior to\n             signing the informed consent form.\n\n         16. PTCA (percutaneous transluminal coronary revascularization) within the past three\n             months prior to signing the informed consent form.\n\n         17. Sustained ventricular tachycardia, atrial fibrillation, atrial flutter or other\n             clinically relevant cardiac arrhythmias as determined by the investigator.\n\n         18. Hypertrophic obstructive cardiomyopathy, aortic stenosis, hemodynamically relevant\n             stenosis of the aortic or mitral valve.\n\n         19. Patients with insulin-dependent diabetes mellitus whose diabetes has not been stable\n             and controlled for at least the past three months as defined by an HbA1C =10%.\n\n         20. Patients who have previously experienced symptoms characteristic of angioedema during\n             treatment with ACE inhibitors or angiotensin II receptor antagonists.\n\n         21. History of drug or alcohol dependency within 6 months prior to signing the informed\n             consent form.\n\n         22. Chronic administration of any medications known to affect blood pressure, except\n             medication allowed by the protocol.\n\n         23. Any investigational therapy within one month of signing the informed consent form.\n\n         24. Known hypersensitivity to any component of the formulations.\n\n         25. Any clinical condition which, in the opinion of the investigator would not allow safe\n             completion of the protocol and safe administration of trial medication.\n\n         26. Inability to comply with the protocol."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "490", 
        "firstreceived_date": "May 2, 2002", 
        "id_info": {
            "nct_id": "NCT00034840", 
            "org_study_id": "502.327"
        }, 
        "intervention": {
            "intervention_name": "telmisartan, valsartan", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Valsartan", 
                "Telmisartan", 
                "Benzoates"
            ]
        }, 
        "keyword": [
            "hypertension", 
            "telmisartan", 
            "valsartan", 
            "boehringer"
        ], 
        "lastchanged_date": "October 31, 2013", 
        "link": [
            {
                "url": "http://trials.boehringer-ingelheim.com/content/dam/internet/opu/clinicaltrial/com_EN/results/502/502.327_U03-3143.pdf"
            }, 
            {
                "url": "http://trials.boehringer-ingelheim.com/content/dam/internet/opu/clinicaltrial/com_EN/results/502/502.327_literature.pdf"
            }
        ], 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Long Beach", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90806"
                    }, 
                    "name": "Memorial Research Medical Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90057"
                    }, 
                    "name": "National Research Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orange", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92868"
                    }, 
                    "name": "Orange County Research Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Farmington", 
                        "country": "United States", 
                        "state": "Connecticut", 
                        "zip": "06030"
                    }, 
                    "name": "University of Conn. Health Services Center, Hypertension and Vascular Disease"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fort Lauderdale", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33308"
                    }, 
                    "name": "Alan Graff"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ft. Lauderdale", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33308"
                    }, 
                    "name": "Greater Ft. Lauderdale Heart Group Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orlando", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32806"
                    }, 
                    "name": "Orlando Clinical Research Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Augusta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30904"
                    }, 
                    "name": "So. Clinical Research and Management, Inc."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60612"
                    }, 
                    "name": "Rush Presbyterian/St. Luke's Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21201"
                    }, 
                    "name": "University of Maryland/Nephrology Clinical Research Unit"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63110"
                    }, 
                    "name": "Washington University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oklahoma City", 
                        "country": "United States", 
                        "state": "Oklahoma", 
                        "zip": "73132"
                    }, 
                    "name": "Oklahoma Cardiovascular and Hypertension Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97232"
                    }, 
                    "name": "Michael A. Azorr, M.D."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Harleysville", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19438"
                    }, 
                    "name": "Harleysville Medical Associates"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Carrollton", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75006"
                    }, 
                    "name": "Trinity Hypertension Research Institute/Punzi Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madison", 
                        "country": "United States", 
                        "state": "Wisconsin", 
                        "zip": "53715"
                    }, 
                    "name": "UW Health/Physicians Plus Center for Clinical Trials"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Calgary", 
                        "country": "Canada", 
                        "state": "Alberta", 
                        "zip": "T2E 7C5"
                    }, 
                    "name": "Heart Health Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mount Pearl", 
                        "country": "Canada", 
                        "state": "Newfoundland and Labrador", 
                        "zip": "A1N 2C3"
                    }, 
                    "name": "Dr. Dennis O'Keefe"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Antigonish", 
                        "country": "Canada", 
                        "state": "Nova Scotia", 
                        "zip": "B2G 2C2"
                    }, 
                    "name": "Dr. William Booth"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Halifax", 
                        "country": "Canada", 
                        "state": "Nova Scotia", 
                        "zip": "B3K 5R3"
                    }, 
                    "name": "MSHJ Research Assoc."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Burlington", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "L7R 2H3"
                    }, 
                    "name": "Dr. Joseph Berlingieri"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Corunna", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "N0N 1G0"
                    }, 
                    "name": "Dr. William Mahoney"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Courtice", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "L1E 3C3"
                    }, 
                    "name": "BBM Clinical Research Ltd."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hamilton", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "L8M 1K7"
                    }, 
                    "name": "Dr. Richard Tytus"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kitchener", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "N2C 2N9"
                    }, 
                    "name": "Total Concept Health Care"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "N6G 2M3"
                    }, 
                    "name": "Centre for Activity and Aging"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sarnia", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "N7T 4X3"
                    }, 
                    "name": "Dr. Martyn Chilvers"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toronto", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "M4N 3M5"
                    }, 
                    "name": "Sunnybrook & Women's College Health Centre"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Granby", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "J2G 8Z9"
                    }, 
                    "name": "Theradev Clinical Research, Inc."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Longueuil", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "J4N 1E1"
                    }, 
                    "name": "Invascor, Longueuil"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint Jerome", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "J7Z 5T3"
                    }, 
                    "name": "Hotel Dieu de St-Jerome"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint Lambert", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "J4P 2H4"
                    }, 
                    "name": "Centre de Cardiologie"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sainte-Foy", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "G1V 4G2"
                    }, 
                    "name": "Centre Hospital Quebec - PAC CHUL Unite de Recherche"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sherbrooke", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "J1H 4J6"
                    }, 
                    "name": "Q&T Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saskatoon", 
                        "country": "Canada", 
                        "state": "Saskatchewan", 
                        "zip": "S7N 0W8"
                    }, 
                    "name": "Royal University Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Canada"
            ]
        }, 
        "official_title": "A Prospective, Randomized, Double-Blind, Forced Titration Trial to Compare the Efficacy of MICARDIS\u00ae (Telmisartan 80 mg p.o. Once Daily) and Diovan\u00ae (Valsartan 160 mg p.o. Once Daily) Using Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Hypertension After Missing One Dose", 
        "overall_official": {
            "affiliation": "Boehringer Ingelheim", 
            "last_name": "Boehringer Ingelheim Study Coordinator", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "August 2002", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Change in the 24-hour mean diastolic blood pressure (DBP), as measured by ABPM after a missed dose", 
                "safety_issue": "No", 
                "time_frame": "after 6 to 8 weeks"
            }, 
            {
                "measure": "Change in the mean DBP during the last 6 hours of the 24-hour dosing interval, as measured by ABPM after an active dose of study medication", 
                "safety_issue": "No", 
                "time_frame": "after 6 to 8 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00034840"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change in 24-hour ABPM mean systolic blood pressure (SBP) after a missed dose", 
                "safety_issue": "No", 
                "time_frame": "after 6 to 8 weeks"
            }, 
            {
                "measure": "Change in the last 6 hour ABPM mean SBP measured after a dose of active treatment", 
                "safety_issue": "No", 
                "time_frame": "after 6 to 8 weeks"
            }, 
            {
                "measure": "Changes in ABPM mean DBP and SBP during other periods of the 24-hour dosing interval after an active dose", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "measure": "Changes in ABPM mean DBP and SBP during other periods of the 24-hour dosing interval after a missed dose", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "measure": "Changes in in-clinic mean seated trough DBP and SBP as measured by manual cuff sphygmomanometer after a missed dose", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "measure": "Changes in in-clinic mean seated trough DBP and SBP as measured by manual cuff sphygmomanometer after an active dose", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "measure": "Responder rates based on ABPM", 
                "safety_issue": "No", 
                "time_frame": "after 6 to 8 weeks"
            }, 
            {
                "measure": "Responder rates based on in-clinic trough cuff blood pressures", 
                "safety_issue": "No", 
                "time_frame": "after 6 to 8 weeks"
            }
        ], 
        "source": "Boehringer Ingelheim", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "GlaxoSmithKline", 
                    "agency_class": "Industry"
                }, 
                {
                    "agency": "Bayer", 
                    "agency_class": "Industry"
                }
            ], 
            "lead_sponsor": {
                "agency": "Boehringer Ingelheim", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2001", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }, 
    "geocoordinates": {
        "Alan Graff": "26.122 -80.143", 
        "BBM Clinical Research Ltd.": "43.912 -78.778", 
        "Centre Hospital Quebec - PAC CHUL Unite de Recherche": "46.803 -71.243", 
        "Centre de Cardiologie": "45.492 -73.502", 
        "Centre for Activity and Aging": "42.979 -81.246", 
        "Dr. Dennis O'Keefe": "47.519 -52.806", 
        "Dr. Joseph Berlingieri": "43.326 -79.799", 
        "Dr. Martyn Chilvers": "42.985 -82.361", 
        "Dr. Richard Tytus": "43.244 -79.889", 
        "Dr. William Booth": "45.623 -61.992", 
        "Dr. William Mahoney": "42.889 -82.453", 
        "Greater Ft. Lauderdale Heart Group Research": "26.122 -80.143", 
        "Harleysville Medical Associates": "40.28 -75.387", 
        "Heart Health Institute": "51.045 -114.057", 
        "Hotel Dieu de St-Jerome": "45.783 -74", 
        "Invascor, Longueuil": "45.537 -73.511", 
        "MSHJ Research Assoc.": "44.649 -63.575", 
        "Memorial Research Medical Clinic": "33.804 -118.158", 
        "Michael A. Azorr, M.D.": "45.523 -122.676", 
        "National Research Institute": "34.052 -118.244", 
        "Oklahoma Cardiovascular and Hypertension Center": "35.468 -97.516", 
        "Orange County Research Center": "33.788 -117.853", 
        "Orlando Clinical Research Center": "28.538 -81.379", 
        "Q&T Research": "45.4 -71.884", 
        "Royal University Hospital": "52.134 -106.648", 
        "Rush Presbyterian/St. Luke's Medical Center": "41.878 -87.63", 
        "So. Clinical Research and Management, Inc.": "33.474 -82.01", 
        "Sunnybrook & Women's College Health Centre": "43.653 -79.383", 
        "Theradev Clinical Research, Inc.": "45.399 -72.722", 
        "Total Concept Health Care": "43.434 -80.478", 
        "Trinity Hypertension Research Institute/Punzi Medical Center": "32.976 -96.89", 
        "UW Health/Physicians Plus Center for Clinical Trials": "43.073 -89.401", 
        "University of Conn. Health Services Center, Hypertension and Vascular Disease": "41.728 -72.84", 
        "University of Maryland/Nephrology Clinical Research Unit": "39.29 -76.612", 
        "Washington University": "38.627 -90.199"
    }
}